Rchr
J-GLOBAL ID:200901086490035478   Update date: Sep. 19, 2024

Nakayama Kenji

ナカヤマ ケンジ | Nakayama Kenji
Affiliation and department:
Job title: Associate Professor
Other affiliations (1):
Research field  (16): Neuroscience - general ,  Psychiatry ,  Pathobiochemistry ,  Clinical pharmacy ,  Pharmaceuticals - health and biochemistry ,  Functional biochemistry ,  Structural biochemistry ,  Tumor diagnostics and therapeutics ,  Tumor diagnostics and therapeutics ,  Tumor diagnostics and therapeutics ,  Urology ,  Healthcare management, medical sociology ,  Other ,  Pathobiochemistry ,  Pathobiochemistry ,  Medical biochemistry
Research keywords  (25): Neurological disease ,  Hair omics ,  qShot MALDI analysis ,  Biomedical mass spectrometry ,  Biochemistry ,  Clinical chemistry ,  Mass Spectrometry ,  Urinomics ,  MALDI-TOF/MS ,  Imaging mass spectrometry ,  Lipidomics ,  Peptidomics ,  Prostate cancer ,  Bladder cancer ,  Urothelial cancer ,  Breast cancer ,  Cell biology ,  Molecular biology ,  Metabolomics ,  Proteomics ,  Wilson's disease ,  Metallothionein ,  Porphyrin ,  Heavy metals ,  Metals
Research theme for competitive and other funds  (11):
  • 2023 - 2026 High-sensitivity qShot MALDI analysis of hair lipids and its clinical application to the evaluation of long-term mental fatigue
  • 2023 - 2024 Simultaneous quantitative analysis for steroid hormones in biomedical samples
  • 2022 - 2023 Building up an Analytical Platform for the qShot MALDI Analysis Method
  • 2018 - 2021 Investigation of novel prostate cancer diagnosis and treatment methods focusing lipid metabolism
  • 2015 - 2018 The exploration of new molecular markers in urine derived from prostate cancer patients by peptidomics
Show all
Papers (101):
  • Kenji Nakayama, Xin Li, Koji Shimizu, Shusuke Akamatsu, Takahiro Inoue, Takashi Kobayashi, Osamu Ogawa, Takayuki Goto. qShot MALDI analysis: A rapid, simple, convenient, and reliable quantitative phospholipidomics approach using MALDI-TOF/MS. Talanta. 2022; 254:124099. doi:10.1016/j.talanta.2022.124099. 2022
  • Yu Miyazaki, Takayuki Goto, Xin Li, Kenji Nakayama, Kosuke Okasho, Masashi Takeda, Kei Mizuno, Hiroko Kimura, Masayuki Uegaki, Takayuki Sumiyoshi, et al. Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy. Cancer Medicine. https://doi.org/10.1002/cam4.5134. 2022. 12. 3. 3328-3342
  • 後藤 崇之, 李 新, 中山 憲司, 井上 貴博, 木村 博子, 林 裕次郎, 澤田 篤郎, 赤松 秀輔, 藤田 和利, 小林 恭, et al. 前立腺癌の新規非侵襲的診断指標としての尿中ホスファチジルコリン/リゾホスファチジルコリン比(The Urinary Phosphatidyl-choline/Lysophosphatidylcholine Ratio as a Novel and Non-invasive Diagnostic Index for Prostate Cancer). 日本泌尿器科学会総会. 2021. 109回. ISA04-10
  • 後藤 崇之, 李 新, 中山 憲司, 井上 貴博, 木村 博子, 林 裕次郎, 澤田 篤郎, 赤松 秀輔, 藤田 和利, 小林 恭, et al. 尿中ホスファチジルコリン/リゾホスファチジルコリン比は前立腺癌の新規診断マーカーとなり得る(京都大学大阪大学共同研究). 西日本泌尿器科学会総会抄録集. 2021. 73回. 198-198
  • Li X, Nakayama K, Goto T, Kimura H, Akamatsu S, Hayashi Y, Fujita K, Kobayashi T, Shimizu K, Nonomura N, et al. High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer. Cancer Sci. 2021; 112:4292-4302. doi:10.1111/cas.15093. 2021. 112. 10. 4292-4302
more...
MISC (149):
  • Kenji Nakayama, Xin Li, Koji Shimizu, Shusuke Akamatsu, Takahiro Inoue, Takashi Kobayashi, Osamu Ogawa, Takayuki Goto. qShot MALDI Phospholipidomics and its Clinical Application. The 2nd International Joint Symposium of JSBMS and MSACL in The 47th Annual Meeting of the Japanese Society for Biomedical Mass Spectrometry. 2022
  • X. Li, K. Nakayama, T. Inoue, T. Goto, S. Akamatsu, T. Kobayashi, K. Shimizu, O. Ogawa. A New strategy in urinary phospholipid analysis: “qShot MALDI”analysis and its clinical applications. The Association for Mass Spectrometry & Advances in the Clinical Lab (MSACL) Connect Seminar 2021. 2021
  • Xin Li, Kenji Nakayama, Takayuki Goto, Shusuke Akamatsu, Koji Shimizu, Osamu Ogawa, Takahiro Inoue. MALDI-TOF/MS Analyses of Urinary Phospholipids and Lysophospholipids as Potential Diagnostic Biomarkers for Prostate Cancer. The Association for Mass Spectrometry: Applications to the Clinical Laboratory (MSACL) 2015 EU, The 2nd European Annual Congress & Exhibition. 2019
  • Xin Li, Kenji Nakayama, Takayuki Goto, Shusuke Akamatsu, Koji Shimizu, Osamu Ogawa, Takahiro Inoue. Urinary phospholipids by MALDI-TOF/MS analyses are potential biomarkers for prostate cancer. The Urological Association of Asia Congress (UAA) 2019. 2019
  • Kita Y, Kobayashi T, Teramoto Y, Tanaka R, Hamada A, Matsumoto K, Murakami K, Saito R, Nakayama K, Takano K, et al. Systematic chemical screening identifies disulfiram as a repositionable drug that enhances sensitivity to cisplatin in bladder cancer: A summary of preclinical studies. European Urology Supplements. 2019. 18. 1. e600-e601
more...
Patents (3):
Books (2):
  • ヒト先天性銅代謝異常症のウィルソン病について(その2)
    (社)北海道総合研究調査会 月刊誌 「しゃりばり」 2008
  • ヒト先天性銅代謝異常症のウィルソン病について(その1)
    (社)北海道総合研究調査会 月刊誌 「しゃりばり」 2008
Education (3):
  • 1996 - 2000 Hokkaido University Graduate School of Science Department of Chemistry
  • 1991 - 1991 Hokkaido University Department of Environmental Medicine, Division of Social Environment, Graduate School of Environmental Science,
  • 1989 - 1991 Hokkaido University Department of Environmental Medicine, Division of Social Environment, Graduate School of Environmental Science,
Work history (21):
  • 2023/09 - 現在 Kyoto University, Graduate School of Medicine Department of Urology Visiting Research Fellow
  • 2023/04 - 現在 Niigata University of Health and Welfare Research Center for BioMedical Analysis Director
  • 2022/04 - 現在 Faculty of Medical Technology, Niigata University of Health and Welfare Department of Clinical Engineering and Medical Technology Associate Professor
  • 2022/09 - 2023/08 Graduate School of Medicine, Kyoto University Department of Breast Surgery Visiting Research Fellow
  • 2021/04 - 2022/03 Kyoto University Graduate School of Medicine Specially Appointed Associate Professor
Show all
Committee career (13):
  • 2024/09 - 現在 Niigata University of Health and Welfare Chairman of Chemical Substances Management Committee
  • 2023/09 - 現在 The Japanese Society of Biochemical Mass Spectrometry Organizer for the 3rd International Joint Symposium of the Japanese Society of Biochemical Mass Spectrometry and the Mass Spectrometry: Applications to the Clinical Lab
  • 2023/09 - 現在 Japanese Society for Biomedical Mass Spectrometry Executive Committee Member of the 49th Annual Meeting of the Japanese Society for Biomedical Mass Spectrometry
  • 2021/07 - 現在 Japanese Society for Biomedical Mass Spectrometry Globalization committee
  • 2020/09 - 現在 The Japanese Society for Biomedical Mass Spectrometry Council member
Show all
Awards (2):
  • 2019/06 - The Association for Mass Spectrometry: Applications to the Clinical Laboratory, Lab Director Grant Award of MSACL 2019 EU.
  • 2015/06 - The Association for Mass Spectrometry: Applications to the Clinical Laboratory, Trainee Travel Grant Award of MSACL 2015 EU.
Association Membership(s) (13):
Niigata Journal of Health and Welfare ,  The International Lipidomics Society ,  The Japanese Cancer Association ,  The Kyoto Biomolecular Mass Spectrometry Society ,  The Association for Mass Spectrometry: Applications to the Clinical Laboratory: MSACL ,  JAPANESE SOCIETY FOR BIOMEDICAL MASS SPECTROMETRY ,  THE MASS SPECTROMETRY SOCIETY OF JAPAN ,  Japan Human Proteome Organization ,  The Hokkaido Association for Laboratory Animal Science ,  The Japan Research Association of Wilson’s Disease ,  Japan Society for Biomedical Research on Trace Elements ,  The Japan Biochemical Society ,  Society for LEC Rat Research
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page